Publications by authors named "Erasmia Giogkaraki"
Article Synopsis
- The COVID-19 pandemic led Greece to put measures like lockdowns and social restrictions in place to help stop the spread of the virus.
- A study conducted during the second national lockdown showed that many people in Greece reported feeling anxious, depressed, stressed, and experiencing trauma.
- The study found that those who were younger, female, had arguments at home, and had trouble accessing food were affected the most, and many turned to coping alone instead of relying on friends and family.
Background: Numerous cross-sectional studies report cognitive impairment in multiple sclerosis (MS), but longitudinal studies with sufficiently long-term follow-up are scarce.
Objective: We aimed to investigate the cognitive 10-year course of a cohort of MS patients.
Methods: 59 patients with clinically isolated syndrome (CIS) or relapsing-remitting (RR) MS were evaluated with Rao's Brief Repeatable Battery of Neuropsychological Tests at baseline and follow-up (at least 10 years later).
The study tested the cognitive reserve hypothesis by quantifying cognitive reserve (CR) and subsequently determining its role in executive function and verbal episodic memory performance. A neuropsychological battery was administered to 383 Greek-Cypriot older adults. A multiple indicators multiple causes (MIMIC) latent construct was utilized to define CR incorporating three indicators: years of education, vocabulary, and reading performance.
View Article and Find Full Text PDFObjective: To investigate the pattern of cognitive impairment in patients with relapsing-remitting (RR), secondary progressive (SP), primary progressive (PP) multiple sclerosis, and patients with clinically isolated syndrome (CIS) suggestive of MS, relative to control participants in the Greek population.
Methods: RR patients (N=75), SP patients (N=29), PP patients (N=23), CIS patients (N=33), and healthy control participants (N=43) were assessed by the Brief Repeatable Battery of Neuropsychological Tests (BRBN).
Results: The overall prevalence of cognitive dysfunction in our patients was 52.